Over 50 people attended IMI’s half-day conference in Krakow, Poland, entitled ‘IMI – New opportunities for drug research in Europe’ on 12 October. The event was a session of the Congress of Polish Biotechnology and the Central European Congress of Life Sciences (Eurobiotech ), which ran from 12-15 October at Krakow’s Nowa Huta Cultural Centre (NCK).
Participants in the special IMI session learnt how IMI works and heard about the many benefits of project participation. The session also featured a spotlight on the benefits and opportunities offered by IMI to researchers in Poland and elsewhere. The IMI session closed with a networking cocktail. In addition, IMI had a stand at the Eurobiotech exhibition.
IMI – reinvigorating pharmaceutical research in Europe 
Andrzej Rys, Directorate-General for Health and Consumers, European Commission and member of the IMI Governing Board
IMI – achievements and opportunities 
Michel Goldman, Executive Director, IMI
The revised IMI Scientific Research Agenda 
Daan Crommelin, Dutch Top Institute Pharma and vice-chair of the IMI Scientific Committee
U-BIOPRED– taking on severe asthma 
Marek Sanak, Jagiellonian University Medical College, Krakow, Poland
Pharmatrain – improving pharmaceutical education in Europe 
Sandor Kerpel-Fronius, Semmelweis University, Budapest, Hungary
Molecular Biotechnology for Health: Operational Programme Innovative Economy grants at Jagiellonian University, possibilities for IMI projects 
Jozef Dulak, Jagiellonian University
What industry brings to IMI 
Richard Bergström, Director General, EFPIA
What IMI means for Poland 
Maciej Bagiński, Gdansk University of Technology
Support for potential participants in health and health-related calls 
Anna Pytko, National Contact Point for Research Programmes of the EU
Researchers from across central Europe and beyond descended on Krakow for the IV Congress of Polish Biotechnology and the Central European Congress of Life Sciences (Eurobiotech), which were combined for the first time.
The event was organised by the Jagiellonian University, the University of Agriculture in Krakow, and the Biotechnology Committee of Polish Academy of Sciences.